Toxicity profile of camrelizumab-based immunotherapy in older adults with advanced cancer
Abstract Immune checkpoint inhibitors (ICIs) have become an important cornerstone of many tumour treatments. However, the toxicity profile of immune-chemotherapy combination treatment approaches among older adult cancer patients is still unclear. Patients with any cancer who received camrelizumab-ba...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Portfolio
2024-08-01
|
| Schriftenreihe: | Scientific Reports |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1038/s41598-024-69944-w |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|